EXLS vs SRPT · P/E 19, rev $1.84B vs rev $1.90B
ExlService Holdings Inc (EXLS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
ExlService Holdings Inc (EXLS) is a information technology services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported EXLS revenue for 2024-12-31 was $1.84B. Net income was $198.3M. Revenue was up 12.7% from 2023-12-31 to 2024-12-31. EXLS currently screens at market cap $4.53B and trailing P/E 18.9.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
EXLS currently screens at market cap $4.53B and trailing P/E 18.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the EXLS and SRPT stock pages for the full models.
Not investment advice.